申请人:THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
公开号:US20140336375A1
公开(公告)日:2014-11-13
The disclosure is directed to compounds identified as allosteric modulators of 5-HT 2CR, as well as pharmaceutical compositions and methods using the same. Certain embodiments also include methods of identifying and methods of synthesizing the compounds. Optimization and development of allosteric 5-HT 2CR modulators that bind sites other than the primary ligand binding site generate novel, highly selective, and potent ligands of 5-HT2CR. Such molecules can be used as small molecule probes for the nervous system and as effective therapeutics for a variety of diseases.
本公开涉及被鉴定为5-HT2CR变构调节剂的化合物,以及使用它们的制药组合物和方法。某些实施方式还包括鉴定和合成这些化合物的方法。通过优化和开发结合除了主要配体结合位点之外的其他位点的变构5-HT2CR调节剂,可以产生新型、高度选择性和有效的5-HT2CR配体。这些分子可以用作神经系统的小分子探针,以及用于多种疾病的有效治疗药物。